Company / Capital Expenditures
Danaher Corporation Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$1.2B
FY2025
5-year range
$636.0M / $1.4B
FY2021-FY2025
Trend
-17.0%
vs FY2024
Sector context
#7 of 151
Health Care
What the data says
Among 151 Health Care companies, Danaher Corporation is in the top 5% for capital expenditures. Capital Expenditures has fluctuated over the past 10 years, ranging from $571M in FY2017 to $1.4B in FY2024.
Based on SEC 10-K filings.
$1.2B in FY2025 with a 5-year CAGR of +14.6%. Top quartile in the Health Care sector.
Declined from $1.2B to $1.2B over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +13.5%
- 5-Year CAGR
- +14.6%
- 10-Year CAGR
- -
Sector benchmark
Top 5% in Health CareTop 5% of 151This company $1.2B Sector average $271.7M
▼
+325.5% above sector average
Key checks
Key Insights
- 5-year CAGR of +14.6%, indicating consistent growth.
- In FY2025, capital expenditures decreased 17.0% year-over-year.
- Ranks #7 out of 151 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.2B | -17.0% |
| FY2024 | $1.4B | +12.3% |
| FY2023 | $1.2B | +56.8% |
| FY2022 | $791.0M | +24.4% |
| FY2021 | $636.0M | +8.9% |
| FY2020 | $584.0M | -8.2% |
| FY2019 | $636.0M | +8.9% |
| FY2018 | $584.0M | +2.3% |
| FY2017 | $570.7M | -3.2% |
| FY2016 | $589.6M | +15.0% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026